1
|
Franciosini G, Carlotti D, Cattani F, De Gregorio A, De Liso V, De Rosa F, Di Francesco M, Di Martino F, Felici G, Pensavalle JH, Leonardi MC, Marafini M, Muscato A, Paiar F, Patera V, Poortmans P, Sciubba A, Schiavi A, Toppi M, Traini G, Trigilio A, Sarti A. IOeRT conventional and FLASH treatment planning system implementation exploiting fast GPU Monte Carlo: The case of breast cancer. Phys Med 2024; 121:103346. [PMID: 38608421 DOI: 10.1016/j.ejmp.2024.103346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Revised: 03/13/2024] [Accepted: 04/01/2024] [Indexed: 04/14/2024] Open
Abstract
Partial breast irradiation for the treatment of early-stage breast cancer patients can be performed by means of Intra Operative electron Radiation Therapy (IOeRT). One of the main limitations of this technique is the absence of a treatment planning system (TPS) that could greatly help in ensuring a proper coverage of the target volume during irradiation. An IOeRT TPS has been developed using a fast Monte Carlo (MC) and an ultrasound imaging system to provide the best irradiation strategy (electron beam energy, applicator position and bevel angle) and to facilitate the optimisation of dose prescription and delivery to the target volume while maximising the organs at risk sparing. The study has been performed in silico, exploiting MC simulations of a breast cancer treatment. Ultrasound-based input has been used to compute the absorbed dose maps in different irradiation strategies and a quantitative comparison between the different options was carried out using Dose Volume Histograms. The system was capable of exploring different beam energies and applicator positions in few minutes, identifying the best strategy with an overall computation time that was found to be completely compatible with clinical implementation. The systematic uncertainty related to tissue deformation during treatment delivery with respect to imaging acquisition was taken into account. The potential and feasibility of a GPU based full MC TPS implementation of IOeRT breast cancer treatments has been demonstrated in-silico. This long awaited tool will greatly improve the treatment safety and efficacy, overcoming the limits identified within the clinical trials carried out so far.
Collapse
Affiliation(s)
- G Franciosini
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy
| | - D Carlotti
- Operative Research Unit of Radiation Oncology, Fondazione Policlinico Universitatio Campus-Bio Medico, Rome, Italy
| | - F Cattani
- Unit of Medical Physics, European Institute of Oncology IRCCS, Milan, Italy
| | - A De Gregorio
- National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy; Sapienza, University of Rome, Department of Physics, Rome, Italy
| | - V De Liso
- S.I.T. Sordina IORT Technologies S.p.A, Aprilia, Italy
| | - F De Rosa
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy
| | | | - F Di Martino
- Centro Pisano Multidisciplinare sulla Ricerca e Implementazione Clinica della Flash Radiotherapy (CPFR), Pisa, Italy; University of Pisa, Department of Physics, Pisa, Italy; Azienda Ospedaliero Universitaria Pisa (AOUP), Fisica Sanitaria, Pisa, Italy; National Institute of Nuclear Physics, INFN, Section of Pisa, Pisa, Italy
| | - G Felici
- S.I.T. Sordina IORT Technologies S.p.A, Aprilia, Italy
| | - J Harold Pensavalle
- S.I.T. Sordina IORT Technologies S.p.A, Aprilia, Italy; Centro Pisano Multidisciplinare sulla Ricerca e Implementazione Clinica della Flash Radiotherapy (CPFR), Pisa, Italy; National Institute of Nuclear Physics, INFN, Section of Pisa, Pisa, Italy
| | - M C Leonardi
- Division of Radiation Oncology, European Institute of Oncology IRCCS, Milan, Italy
| | - M Marafini
- National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Rome, Italy
| | - A Muscato
- National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy; Specialty School of Medical Physics, La Sapienza University of Rome, Rome, Italy
| | - F Paiar
- Centro Pisano Multidisciplinare sulla Ricerca e Implementazione Clinica della Flash Radiotherapy (CPFR), Pisa, Italy; Azienda Ospedaliero Universitaria Pisa (AOUP), Fisica Sanitaria, Pisa, Italy
| | - V Patera
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy
| | - P Poortmans
- Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium
| | - A Sciubba
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Frascati National Laboratories (LNF), Rome, Italy
| | - A Schiavi
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy
| | - M Toppi
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy
| | - G Traini
- National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy
| | - A Trigilio
- Sapienza, University of Rome, Department of Physics, Rome, Italy; National Institute of Nuclear Physics, INFN, Frascati National Laboratories (LNF), Rome, Italy
| | - A Sarti
- Sapienza, University of Rome, Department of Scienze di Base e Applicate all'Ingegneria, Rome, Italy; National Institute of Nuclear Physics, INFN, Section of Rome I, Rome, Italy.
| |
Collapse
|
2
|
Carlotti D, Muscato A, De Gregorio A, de Simoni M, Fiore M, Franciosini G, Insero T, Marafini M, Marè V, Mirabelli R, Palumbo L, Ramella S, Sarti A, Schiavi A, Toppi M, Traini G, Trigilio A, Patera V. New Advantage in Stereotactic Treatment of Lung and Pancreatic Cancer. Performance of Ultra-High Energy Electron (VHEE) Therapy Adjuvanted to the FLASH Effect: Clinical Implications and Treatment Plans Analysis. Int J Radiat Oncol Biol Phys 2023; 117:e648-e649. [PMID: 37785927 DOI: 10.1016/j.ijrobp.2023.06.2068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Very High-Energy Electron (VHEE) beams delivered at ultra-high dose rates and hence profiting from the FLASH effect, may be a viable alternative to conventional treatment plans for the treatment of deep-seated tumors. Experimental data support the evidence of a considerable normal tissue sparing effect when treatments are delivered with dose rates much larger (100 times or more) compared to the conventional ones. Lung cancer and pancreatic cancer are considered the two biggest cancer killers. We urgently need more research in these areas, more awareness that support improvement in treatment strategies. To evaluate the potential of FLASH VHEE irradiation in these two clinical situations, we investigated the achievable sparing of healthy tissues and critical dose-limiting structures, with the goal of performing a higher dose prescription. MATERIALS/METHODS The study on the potential of VHEE for the stereotactic treatment of pancreatic and lung lesions was carried out on two clinical cases treated with Volumetric Modulated Arc Therapy (VMAT) techniques at University Hospital Campus Bio-Medico of Rome. The Planning Target Volume (PTV) was identified and the constraints on the Organs at Risk (OAR) and details on the irradiation approach were defined. The VHEE plan was designed to optimize the dose delivery to best activate the modelled FLASH effect based on the current experimental knowledge. In particular the impact on a dose threshold to activate the effect was studied. The VHEE treatment plan was based on an accurate Monte Carlo simulation of the electrons interactions and the results achievable with different FLASH effect models were studied. The simulation allowed the estimation of dose maps, which were used as input to an optimization algorithm that modified the fluence of each beam to meet treatment prescriptions in terms of dose to PTV. At the end the VHEE DVH plans were compared to VMAT plans. RESULTS The results demonstrated that FLASH therapy with VHEE beams of 70-130 MeV, could represent a promising alternative to standard radiotherapy allowing a comparable sparing of the healthy tissues. In the case of pancreatic cancer, the Dose Volume Histograms (DVH) showed how such a technique can be effective in sparing the duodenum. In case of lung cancers, the result showed how pulmonary tissue sparing can lead to a substantial reduction of pulmonary toxicity in comparison with the VMAT technique. CONCLUSION In the case of pancreatic cancer and assuming a non-negligible contribution from the FLASH effect, the DVH showed how the duodenum healthy tissue sparing could allow a higher dose to be prescribed at the target while keeping the constraints respected, improving the therapeutic ratio. In the case of lung cancer, the advantages of the technique are additionally increased by the significant benefit that could be related to the treatment delivery time reduction (<1s) and to the corresponding advantage coming from a reduced organ movement that translates in a lower risk of lung toxicity.
Collapse
Affiliation(s)
- D Carlotti
- Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
| | - A Muscato
- Scuola Post-Laurea in Fisica Medica, Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza Università di Roma, Rome, Italy
| | - A De Gregorio
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy; INFN Sezione di Roma I, Rome, Italy
| | - M de Simoni
- INFN Sezione di Roma I, Rome, Italy; Departement of Medical Physics Ludwig Maximilians Universitat Munchen (LMU), Munich, Germany
| | - M Fiore
- Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Radiation Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy
| | | | - T Insero
- Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - M Marafini
- INFN Sezione di Roma I, Rome, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Rome, Italy
| | - V Marè
- Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy
| | - R Mirabelli
- INFN Sezione di Roma I, Rome, Italy; Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - L Palumbo
- INFN Sezione di Roma I, Rome, Italy; Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - S Ramella
- Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy; Radiation Oncology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy
| | - A Sarti
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - A Schiavi
- INFN Sezione di Roma I, Rome, Italy; Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - M Toppi
- INFN Sezione di Roma I, Rome, Italy
| | - G Traini
- INFN Sezione di Roma I, Rome, Italy
| | - A Trigilio
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy; INFN Sezione di Roma I, Rome, Italy
| | - V Patera
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| |
Collapse
|
3
|
Franciosini G, Battistoni G, Cerqua A, De Gregorio A, De Maria P, De Simoni M, Dong Y, Fischetti M, Marafini M, Mirabelli R, Muscato A, Patera V, Salvati F, Sarti A, Sciubba A, Toppi M, Traini G, Trigilio A, Schiavi A. GPU-accelerated Monte Carlo simulation of electron and photon interactions for radiotherapy applications. Phys Med Biol 2023; 68. [PMID: 36356308 DOI: 10.1088/1361-6560/aca1f2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2022] [Accepted: 11/10/2022] [Indexed: 11/12/2022]
Abstract
Objective. The Monte Carlo simulation software is a valuable tool in radiation therapy, in particular to achieve the needed accuracy in the dose evaluation for the treatment plans optimisation. The current challenge in this field is the time reduction to open the way to many clinical applications for which the computational time is an issue. In this manuscript we present an innovative GPU-accelerated Monte Carlo software for dose valuation in electron and photon based radiotherapy, developed as an update of the FRED (Fast paRticle thErapy Dose evaluator) software.Approach. The code transports particles through a 3D voxel grid, while scoring their energy deposition along their trajectory. The models of electromagnetic interactions in the energy region between 1 MeV-1 GeV available in literature have been implemented to efficiently run on GPUs, allowing to combine a fast tracking while keeping high accuracy in dose assessment. The FRED software has been bench-marked against state-of-art full MC (FLUKA, GEANT4) in the realm of two different radiotherapy applications: Intra-Operative Radio Therapy and Very High Electron Energy radiotherapy applications.Results. The single pencil beam dose-depth profiles in water as well as the dose map computed on non-homogeneous phantom agree with full-MCs at 2% level, observing a gain in processing time from 200 to 5000.Significance. Such performance allows for computing a plan with electron beams in few minutes with an accuracy of ∼%, demonstrating the FRED potential to be adopted for fast plan re-calculation in photon or electron radiotherapy applications.
Collapse
Affiliation(s)
- G Franciosini
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - G Battistoni
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Milano, Italy
| | - A Cerqua
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - A De Gregorio
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - P De Maria
- Scuola post-laurea in Fisica Medica, Dipartimento di Scienze e Biotecnologie medico-chirurgiche, Sapienza Universitá di Roma, Roma, Italy
| | - M De Simoni
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - Y Dong
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Milano, Italy
| | - M Fischetti
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - M Marafini
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Museo Storico della Fisica e Centro Studi e Ricerche 'E. Fermi', Roma, Italy
| | - R Mirabelli
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - A Muscato
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Scuola post-laurea in Fisica Medica, Dipartimento di Scienze e Biotecnologie medico-chirurgiche, Sapienza Universitá di Roma, Roma, Italy
| | - V Patera
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - F Salvati
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - A Sarti
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - A Sciubba
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy.,Istituto Nazionale di Fisica Nucleare (INFN)- Laboratori Nazionali di Frascati, Frascati, Italy
| | - M Toppi
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - G Traini
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy
| | - A Trigilio
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - A Schiavi
- Istituto Nazionale di Fisica Nucleare (INFN) - Sezione di Roma, Italy.,Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy
| |
Collapse
|
4
|
Baldi E, Traini G, Tamburrino L, Bini F, Raffaelli G, Vignozzi L, Marchiani S. P-037 A fluorescent probe for Reactive Oxygen Species (ROS) detection identifies spermatozoa with a better reporductive performance. Hum Reprod 2022. [DOI: 10.1093/humrep/deac107.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Could Reactive Oxygen Species (ROS) detected in human spermatozoa represent a predictive marker of fertilization ability?
Summary answer
ROS detected by CellROX® Orange probe is related to a better sperm quality and function, indicating the sensitivity of the probe to identify physiological ROS.
What is known already
Oxidative stress (OS), defined as an unbalance between ROS production and antioxidant defenses, is one of the causes of male infertility. A small amount of ROS is necessary for the physiological sperm function, however high ROS levels could impair fertility potential inducing damages at membrane, protein and DNA levels.
Previous studies performed by using different methods and probes for OS evaluation in semen or in spermatozoa highlighted the negative role of ROS on sperm functions. However, such studies were not conclusive because of the small number of included subjects and of high variability in the cohorts.
Study design, size, duration
Observational study conducted on 73 male partners of infertile couples attended consecutively to the Andrology Laboratory of Careggi University Hospital of Florence from September to December 2021. Analyses were performed on both washed and Swim-up selected spermatozoa.
Participants/materials, setting, methods
After routine semen analysis, washed and Swim-up selected spermatozoa were incubated with CellRox®Orange (a fluorescent probe able to reveal OS in viable cells), at the concentration of 1 µM for 30 minutes at 37°C, 5%CO2, and revealed by flow cytometry. Sperm DNA fragmentation (by TUNEL/PI method), sperm kinematic parameters and hyperactivated motility (by C.A.S.A. system) were also assessed. In some samples a double staining with CellRox®Orange and Annexin V (which stains phosphatidylserine externalization) was performed.
Main results and the role of chance
We found that the percentage of spermatozoa positive to CellRox® Orange is positively correlated with routine seminal parameters. Although this result appears in contrast with most studies in literature reporting negative correlations between OS and semen parameters, it can be explained by the fact that the probe is specific for viable spermatozoa characterized by a better motility and morphology. Considering the importance of distinguishing between positive and negative ROS in spermatozoa, we further investigated the significance of ROS detected by this probe. To understand whether the probe marks spermatozoa with a better quality, CellRox® Orange positivity was evaluated in Swim-up selected spermatozoa finding significantly higher levels of CellRox® Orange positivity respect to unselected samples. Furthermore, the fact that most of the CellRox® Orange positive spermatozoa were negative for Annexin V (which reveals cells with early signs of apoptosis) is a further confirmation of the good quality of CellRox® Orange positive spermatozoa.
Another evidence is represented by the finding that we observed a negative correlation between OS detected by CellRox® Orange and sperm DNA fragmentation, although several studies have shown a positive relationship between these two parameters (when OS is measured by different probes).
Limitations, reasons for caution
Up to now, the study involved a limited number of subjects. Further experiments should be performed to increase the number of subjects in order to confirm the results.
Wider implications of the findings
Results of this study together with those previously published evidence that different OS is detected depending on which probe is used. CellRox® Orange seems to be sensible for physiological ROS detection, therefore, it could be employed in future studies aimed to evaluate the association between OS and assisted reproduction outcomes.
Trial registration number
not applicable
Collapse
Affiliation(s)
- E Baldi
- University of Florence, Medicina Sperimentale e Clinica , Florence, Italy
| | - G Traini
- University of Florence, Scienze Biomediche Sperimentali E Cliniche Mario Serio , Florence, Italy
| | - L Tamburrino
- University of Florence, Medicina Sperimentale e Clinica , Florence, Italy
| | - F Bini
- University of Florence, Medicina Sperimentale e Clinica , Florence, Italy
| | - G Raffaelli
- University of Florence, Medicina Sperimentale e Clinica , Florence, Italy
| | - L Vignozzi
- University of Florence, Scienze Biomediche Sperimentali E Cliniche Mario Serio , Florence, Italy
| | - S Marchiani
- University of Florence, Scienze Biomediche Sperimentali E Cliniche Mario Serio , Florence, Italy
| |
Collapse
|
5
|
De Simoni M, Baroni G, Battistoni G, Bisogni M, Cerello P, Ciocca M, Donetti M, Dong Y, Embriaco A, Ferrero V, Fiorina E, Fischetti M, Franciosini G, Giacchi G, Kraan A, Luongo C, Maggi M, Mancini Terracciano C, Marafini M, Malekzadeh E, Mattei I, Mazzoni E, Mirandola A, Morrocchi M, Muraro S, Patera V, Pennazio F, Schiavi A, Solfaroli-Camillucci E, Sportelli G, Tampellini S, Toppi M, Traini G, Trigilio A, Vischioni B, Vitolo V, Carlotti D, De Gregorio A, Sarti A. PD-0897 In vivo verification by detection of charged fragments in carbon ion therapy treatments at CNAO. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02976-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Trigilio A, Carlotti D, De Gregorio A, De Maria P, De Simoni M, Fischetti M, Franciosini G, Garbini M, Marafini M, Muscato A, Patera V, Schiavi A, Sciubba A, Toppi M, Traini G, Sarti A. OC-0279 FlashDC project: development of a beam monitor for FLASH therapy. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02537-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
7
|
Felici G, Galante F, Barone S, Di Francesco M, Grasso L, Pacitti M, Patera V, Sarti A, Fischetti M, Trigilio A, Toppi M, Traini G, Palumbo L, Faillace L, Mostacci A, Migliorati M, Giuliano L, Schiavi A, Marafini M, De Simoni M, Battistoni G, Di Martino F, Franciosini G, Paiar F, Linsalata S. A PRELIMINARY STUDY ON RADIATION PROTECTION REQUIREMENTS FOR A FLASH IOERT LINAC. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01669-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
8
|
Trigilio A, De Maria P, De Simoni M, Fischetti M, Franciosini G, Marafini M, Muscato A, Pacilio M, Rubeca D, Sarti A, Schiavi A, Schwarz M, Tombolini V, Toppi M, Traini G, Patera V. A FEASIBILITY STUDY OF DEEP SEATED TUMOR TREATMENTS COMBINING FLASH EFFECT AND VERY HIGH ENERGY ELECTRON BEAMS. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01651-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
9
|
Toppi M, De Gregorio A, De Maria P, De Simoni M, Fischetti M, Franciosini G, Marafini M, Patera V, Schiavi A, Sciubba A, Traini G, Trigilio A, Sarti A. FLASHDC PROJECT: DEVELOPMENT OF A BEAM MONITOR FOR FLASH RADIOTHERAPY. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01625-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
10
|
Franciosini G, Sarti A, Barone S, De Maria P, De Simoni M, Di Francesco M, Di Martino F, Felici G, Fischetti M, Galante F, Grasso L, Marafini M, Pacitti M, Patera V, Schiavi A, Toppi M, Traini G, Trigilio A. FLASH Mechanisms Track (Oral Presentations) A FEASIBILITY STUDY OF IORT-FLASH USING A GPU-BASED FAST MONTE CARLO. Phys Med 2022. [DOI: 10.1016/s1120-1797(22)01515-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
11
|
Fischetti M, Baroni G, Battistoni G, Bisogni G, Cerello P, Ciocca M, De Maria P, De Simoni M, Di Lullo B, Donetti M, Dong Y, Embriaco A, Ferrero V, Fiorina E, Franciosini G, Galante F, Kraan A, Luongo C, Magi M, Mancini-Terracciano C, Marafini M, Malekzadeh E, Mattei I, Mazzoni E, Mirabelli R, Mirandola A, Morrocchi M, Muraro S, Patera V, Pennazio F, Schiavi A, Sciubba A, Solfaroli Camillocci E, Sportelli G, Tampellini S, Toppi M, Traini G, Valle SM, Vischioni B, Vitolo V, Sarti A. Inter-fractional monitoring of [Formula: see text]C ions treatments: results from a clinical trial at the CNAO facility. Sci Rep 2020; 10:20735. [PMID: 33244102 PMCID: PMC7693236 DOI: 10.1038/s41598-020-77843-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2020] [Accepted: 11/13/2020] [Indexed: 12/26/2022] Open
Abstract
The high dose conformity and healthy tissue sparing achievable in Particle Therapy when using C ions calls for safety factors in treatment planning, to prevent the tumor under-dosage related to the possible occurrence of inter-fractional morphological changes during a treatment. This limitation could be overcome by a range monitor, still missing in clinical routine, capable of providing on-line feedback. The Dose Profiler (DP) is a detector developed within the INnovative Solution for In-beam Dosimetry in hadronthErapy (INSIDE) collaboration for the monitoring of carbon ion treatments at the CNAO facility (Centro Nazionale di Adroterapia Oncologica) exploiting the detection of charged secondary fragments that escape from the patient. The DP capability to detect inter-fractional changes is demonstrated by comparing the obtained fragment emission maps in different fractions of the treatments enrolled in the first ever clinical trial of such a monitoring system, performed at CNAO. The case of a CNAO patient that underwent a significant morphological change is presented in detail, focusing on the implications that can be drawn for the achievable inter-fractional monitoring DP sensitivity in real clinical conditions. The results have been cross-checked against a simulation study.
Collapse
Affiliation(s)
- M. Fischetti
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
| | - G. Baroni
- Dipartimento di Elettronica Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy
| | | | - G. Bisogni
- INFN Sezione di Pisa, Pisa, Italy
- Dipartimento di Fisica “E. Fermi”, Università di Pisa, Pisa, Italy
| | | | - M. Ciocca
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - P. De Maria
- Scuola di Specializzazione di Fisica Medica, Sapienza Università di Roma, Rome, Italy
| | - M. De Simoni
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
| | - B. Di Lullo
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - M. Donetti
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - Y. Dong
- INFN Sezione di Milano, Milan, Italy
- Dipartimento di Fisica, Università degli Studi di Milano, Milan, Italy
| | | | | | - E. Fiorina
- INFN Sezione di Torino, Turin, Italy
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - G. Franciosini
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
| | - F. Galante
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - A. Kraan
- INFN Sezione di Pisa, Pisa, Italy
| | - C. Luongo
- INFN Sezione di Pisa, Pisa, Italy
- Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Pisa, Italy
| | - M. Magi
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - C. Mancini-Terracciano
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
| | - M. Marafini
- INFN Sezione di Roma I, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| | - E. Malekzadeh
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - I. Mattei
- INFN Sezione di Milano, Milan, Italy
| | | | - R. Mirabelli
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| | - A. Mirandola
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - M. Morrocchi
- INFN Sezione di Pisa, Pisa, Italy
- Dipartimento di Fisica “E. Fermi”, Università di Pisa, Pisa, Italy
| | - S. Muraro
- INFN Sezione di Milano, Milan, Italy
| | - V. Patera
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| | | | - A. Schiavi
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
| | - A. Sciubba
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione dei Laboratori di Frascati, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| | - E. Solfaroli Camillocci
- Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
- Scuola di Specializzazione in Fisica Medica, Sapienza Università di Roma, Rome, Italy
| | - G. Sportelli
- INFN Sezione di Pisa, Pisa, Italy
- Dipartimento di Fisica “E. Fermi”, Università di Pisa, Pisa, Italy
| | - S. Tampellini
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - M. Toppi
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione dei Laboratori di Frascati, Rome, Italy
| | - G. Traini
- INFN Sezione di Roma I, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| | | | - B. Vischioni
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - V. Vitolo
- CNAO Centro Nazionale di Adroterapia Oncologica, Pavia, Italy
| | - A. Sarti
- Dipartimento di Scienze di Base e Applicate per l’Ingegneria, Sapienza Università di Roma, Rome, Italy
- INFN Sezione di Roma I, Rome, Italy
- Museo Storico della Fisica e Centro Studi e Ricerche “E. Fermi”, Rome, Italy
| |
Collapse
|
12
|
Morganti S, Bertani E, Bocci V, Colandrea M, Collamati F, Cremonesi M, De Simoni M, Ferrari E, Fischetti M, Funicelli L, Grana CM, Mancini-Terracciano C, Mirabelli R, Papi S, Pisa E, Solfaroli-Camillocci E, Traini G, Faccini R. Tumor-non-tumor discrimination by a β - detector for Radio Guided Surgery on ex-vivo neuroendocrine tumors samples. Phys Med 2020; 72:96-102. [PMID: 32247965 DOI: 10.1016/j.ejmp.2020.03.021] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2019] [Revised: 03/20/2020] [Accepted: 03/23/2020] [Indexed: 01/06/2023] Open
Abstract
This paper provides a first insight of the potential of the β- Radio Guided Surgery (β--RGS) in a complex surgical environment like the abdomen, where multiple sources of background concur to the signal at the tumor site. This case is well reproduced by ex-vivo samples of 90Y-marked Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP NET) in the bowel. These specimens indeed include at least three wide independent sources of background associated to three anatomical districts (mesentery, intestine, mucose). The study is based on the analysis of 37 lesions found on 5 samples belonging to 5 different patients. We show that the use of electrons, a short range particle, instead of γ particles, allows to limit counts read on a lesion to the sum of the tumor signal plus the background generated by the sole hosting district.The background on adjacent districts in the same specimen/patient is found to differ up to a factor 4, showing how the specificity and sensitivity of the β--RGS technique can be fully exploited only upon a correct measurement of the contributing background. This locality has been used to set a site-specific cut-off algorithm to discriminate tumor and healthy tissue with a specificity of 100% and a sensitivity, on this test data sample, close to 100%. Factors influencing the sensitivity are also discussed. One of the specimens set allowed us evaluate the volume of the lesions, thus concluding that the probe was able to detect lesions as small as 0.04 mL in that particular case.
Collapse
Affiliation(s)
- S Morganti
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy
| | - E Bertani
- Division of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - V Bocci
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy
| | - M Colandrea
- Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - F Collamati
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy.
| | - M Cremonesi
- Radiation Research Unit, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - M De Simoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
| | - E Ferrari
- Division of Medical Physics, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - M Fischetti
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy
| | - L Funicelli
- Division of Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - C M Grana
- Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - C Mancini-Terracciano
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
| | - R Mirabelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy; Dipartimento Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy; Museo Storico della Fisica e Centro Studi e Ricerche E. Fermi, Rome, Italy
| | - S Papi
- Division of Nuclear Medicine, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - E Pisa
- Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - E Solfaroli-Camillocci
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Scuola di Specializzazione in Fisica Medica, Sapienza Università di Roma, Rome, Italy
| | - G Traini
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy; Dipartimento Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Rome, Italy; Museo Storico della Fisica e Centro Studi e Ricerche E. Fermi, Rome, Italy
| | - R Faccini
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Rome, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Rome, Italy
| |
Collapse
|
13
|
Mattei I, Alexandrov A, Alunni Solestizi L, Ambrosi G, Argiro S, Bartosik N, Battistoni G, Belcari N, Biondi S, Bisogni MG, Bruni G, Camarlinghi N, Carra P, Catanzani E, Ciarrocchi E, Cerello P, Clozza A, Colombi S, De Lellis G, Del Guerra A, De Simoni M, Di Crescenzo A, Donetti M, Dong Y, Durante M, Embriaco A, Emde M, Faccini R, Ferrero V, Ferroni F, Fiandrini E, Finck C, Fiorina E, Fischetti M, Francesconi M, Franchini M, Galli L, Gentile V, Hetzel R, Hild S, Iarocci E, Ionica M, Kanxheri K, Kraan AC, Lante V, Lauria A, La Tessa C, Lopez Torres E, Massimi C, Marafini M, Mengarelli A, Mirabelli R, Montesi MC, Morone MC, Morrocchi M, Muraro S, Narici L, Pastore A, Pastrone N, Patera V, Pennazio F, Placidi P, Pullia M, Ramello L, Ridolfi R, Rosso V, Rovituso M, Sanelli C, Sartorelli G, Sato O, Savazzi S, Scavarda L, Schiavi A, Schuy C, Scifoni E, Sciubba A, Secher A, Selvi M, Servoli L, Silvestre G, Sitta M, Spighi R, Spiriti E, Sportelli G, Stahl A, Tomassini S, Tommasino F, Traini G, Toppi M, Valeri T, Valle SM, Vanstalle M, Villa M, Weber U, Zoccoli A, Sarti A. Measurement of 12C Fragmentation Cross Sections on C, O, and H in the Energy Range of Interest for Particle Therapy Applications. IEEE Trans Radiat Plasma Med Sci 2020. [DOI: 10.1109/trpms.2020.2972197] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
14
|
Collamati F, Moretti R, Alunni-Solestizi L, Bocci V, Cartoni A, Collarino A, De Simoni M, Faccini R, Fischetti M, Giordano A, Maccora D, Mancini-Terracciano C, Mirabelli R, Scotognella T, Solfaroli-Camillocci E, Traini G, Morganti S. Characterisation of a β detector on positron emitters for medical applications. Phys Med 2019; 67:85-90. [PMID: 31704391 DOI: 10.1016/j.ejmp.2019.10.025] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2019] [Revised: 10/02/2019] [Accepted: 10/09/2019] [Indexed: 12/21/2022] Open
Abstract
PURPOSE Radio Guided Surgery (RGS) is a technique that helps the surgeon to achieve an as complete as possible tumor resection, thanks to the intraoperative detection of particles emitted by a radio tracer that bounds to tumoral cells. In the last years, a novel approach to this technique has been proposed that, exploiting β- emitting radio tracers, overtakes some limitations of established γ-RGS. In this context, a first prototype of an intraoperative β particle detector, based on a high light yield and low density organic scintillator, has been developed and characterised on pure β- emitters, like 90Y. The demonstrated very high efficiency to β- particles, together with the remarkable transparency to photons, suggested the possibility to use this detector also with β+ emitting sources, that have plenty of applications in nuclear medicine. In this paper, we present upgrades and optimisations performed to the detector to reveal such particles. METHODS Laboratory measurement have been performed on liquid Ga68 source, and were used to validate and tune a Monte Carlo simulation. RESULTS The upgraded detector has an ~80% efficiency to electrons above ~110keV, reaching a plateau value of ~95%. At the same time, the probe is substantially transparent to photons below ~200keV, reaching a plateau value of ~3%. CONCLUSIONS The new prototype seems to have promising characteristics to perform RGS also with β+ emitting isotopes.
Collapse
Affiliation(s)
- F Collamati
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy
| | - R Moretti
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - L Alunni-Solestizi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, Perugia, Italy
| | - V Bocci
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy
| | - A Cartoni
- Dipartimento di Chimica, Sapienza Università di Roma, Roma, Italy
| | - A Collarino
- Unità di Medicina Nucleare, Fondazione Policlinico Gemelli IRCCS, L.go A. Gemelli 8, Roma, Italy
| | - M De Simoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - R Faccini
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - M Fischetti
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Roma, Italy
| | - A Giordano
- Unità di Medicina Nucleare, Fondazione Policlinico Gemelli IRCCS, L.go A. Gemelli 8, Roma, Italy; Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Roma, Italy
| | - D Maccora
- Unità di Medicina Nucleare, Fondazione Policlinico Gemelli IRCCS, L.go A. Gemelli 8, Roma, Italy; Università Cattolica del Sacro Cuore, L.go F. Vito 1, 00168 Roma, Italy
| | | | - R Mirabelli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche E. Fermi, Rome, Italy
| | - T Scotognella
- Unità di Medicina Nucleare, Fondazione Policlinico Gemelli IRCCS, L.go A. Gemelli 8, Roma, Italy
| | - E Solfaroli-Camillocci
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; Scuola di Specializzazione in Fisica Medica, Sapienza Università di Roma, Roma, Italy.
| | - G Traini
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche E. Fermi, Rome, Italy
| | - S Morganti
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma, Roma, Italy
| |
Collapse
|
15
|
Savarese A, Probo M, Locatelli C, Gazzonis AL, Zanzani SA, Traini G, Vitiello T, Brambilla PG. Iron status in dogs with myxomatous mitral valve disease. Pol J Vet Sci 2019; 21:507-515. [PMID: 30468339 DOI: 10.24425/122625] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In humans, iron deficiency represents a relevant occurrence in heart failure (HF), with or without anaemia, and is associated with the worst outcome. Moreover, chronic kidney disease (CKD) is a well-known comorbidity of HF and is strongly associated with the risk of developing anaemia. The most common cause of HF in dogs is myxomatous mitral valve disease (MMVD). To the best of our knowledge, no studies have examined the iron status in dogs with HF, with and without CKD. The aim of this retrospective study was to evaluate the iron status in dogs affected by MMVD and how strong is the relation with HF. The retrospective study included 54 dogs with complete case records, echocardiography and laboratory analyses. Iron status was evaluated by measuring serum iron concentration (SIC), un- saturated iron binding capacity (UIBC), total iron binding capacity (TIBC), and percentage of saturation (%SAT). The prevalence of dogs showing low serum iron concentration (SIC) was 18% in the whole population, 33% in symptomatic patients, 100% in dogs with acute decompensated HF. No signif- icant differences in SIC, UIBC, TIBC and %SAT median values were found among dogs classi- fied in different ACVIM (American College of Veterinary Internal Medicine) classes, between symptomatic and non-symptomatic patients, and among IRIS (International Renal Interest Soci- ety) classes. Azotemic and non-azotemic patients presented a significant difference in SIC mean values (p=0.02). Generalised linear model (GLM) revealed that dogs with low SIC were at high- er risk of being included in a higher ACVIM class (OR=6.383, p-value=0.014). Log-rank analysis showed shorter survival in dogs with low SIC (p=0.020), multivariate Cox analysis revealed that only HF symptoms can affect survival.
Collapse
Affiliation(s)
- A Savarese
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - M Probo
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - C Locatelli
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - A L Gazzonis
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - S A Zanzani
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - G Traini
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - T Vitiello
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| | - P G Brambilla
- Department of Veterinary Medicine (DIMEVET), University of Milan, via Celoria 10, 20133 Milan, Italy
| |
Collapse
|
16
|
Rucinski A, Traini G, Roldan AB, Battistoni G, De Simoni M, Dong Y, Fischetti M, Frallicciardi PM, Gioscio E, Mancini-Terracciano C, Marafini M, Mattei I, Mirabelli R, Muraro S, Sarti A, Schiavi A, Sciubba A, Solfaroli Camillocci E, Valle SM, Patera V. Secondary radiation measurements for particle therapy applications: Charged secondaries produced by 16O ion beams in a PMMA target at large angles. Phys Med 2019; 64:45-53. [PMID: 31515035 DOI: 10.1016/j.ejmp.2019.06.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/24/2018] [Revised: 05/23/2019] [Accepted: 06/07/2019] [Indexed: 11/27/2022] Open
Abstract
Particle therapy is a therapy technique that exploits protons or light ions to irradiate tumor targets with high accuracy. Protons and 12C ions are already used for irradiation in clinical routine, while new ions like 4He and 16O are currently being considered. Despite the indisputable physical and biological advantages of such ion beams, the planning of charged particle therapy treatments is challenged by range uncertainties, i.e. the uncertainty on the position of the maximal dose release (Bragg Peak - BP), during the treatment. To ensure correct 'in-treatment' dose deposition, range monitoring techniques, currently missing in light ion treatment techniques, are eagerly needed. The results presented in this manuscript indicate that charged secondary particles, mainly protons, produced by an 16O beam during target irradiation can be considered as candidates for 16O beam range monitoring. Hereafter, we report on the first yield measurements of protons, deuterons and tritons produced in the interaction of an 16O beam impinging on a PMMA target, as a function of detected energy and particle production position. Charged particles were detected at 90° and 60° with respect to incoming beam direction, and homogeneous and heterogeneous PMMA targets were used to probe the sensitivity of the technique to target inhomogeneities. The reported secondary particle yields provide essential information needed to assess the accuracy and resolution achievable in clinical conditions by range monitoring techniques based on secondary charged radiation.
Collapse
Affiliation(s)
- A Rucinski
- INFN - Sezione di Roma 1, Italy; Institute of Nuclear Physics PAN, Krakow, Poland
| | - G Traini
- Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy.
| | | | | | - M De Simoni
- Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy
| | - Y Dong
- INFN - Sezione di Milano, Italy; Dipartimento di Fisica, Università di Milano, Milano, Italy
| | - M Fischetti
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy
| | - P M Frallicciardi
- Azienda Ospedaliero-Universitaria 'Ospedali Riuniti di Foggia', Foggia, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - E Gioscio
- Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - C Mancini-Terracciano
- INFN - Sezione di Roma 1, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy
| | - M Marafini
- Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy; INFN - Sezione di Roma 1, Italy
| | | | - R Mirabelli
- Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | | | - A Sarti
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy; Laboratori Nazionali di Frascati dell'INFN, Frascati, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - A Schiavi
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy
| | - A Sciubba
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - E Solfaroli Camillocci
- INFN - Sezione di Roma 1, Italy; Dipartimento di Fisica, Sapienza Università di Roma, Roma, Italy; Scuola di Specializzazione in Fisica Medica, Sapienza Università di Roma, Roma, Italy
| | - S M Valle
- INFN - Sezione di Milano, Italy; Dipartimento di Fisica, Università di Milano, Milano, Italy
| | - V Patera
- Dipartimento di Scienze di Base e Applicate per Ingegneria, Sapienza Università di Roma, Roma, Italy; INFN - Sezione di Roma 1, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| |
Collapse
|
17
|
Traini G, Mattei I, Battistoni G, Bisogni MG, De Simoni M, Dong Y, Embriaco A, Fischetti M, Magi M, Mancini-Terracciano C, Marafini M, Mirabelli R, Muraro S, Patera V, Schiavi A, Sciubba A, Solfaroli Camillocci E, Valle SM, Sarti A. Review and performance of the Dose Profiler, a particle therapy treatments online monitor. Phys Med 2019; 65:84-93. [PMID: 31437603 DOI: 10.1016/j.ejmp.2019.07.010] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 06/24/2019] [Accepted: 07/14/2019] [Indexed: 11/27/2022] Open
Abstract
Particle therapy (PT) can exploit heavy ions (such as He, C or O) to enhance the treatment efficacy, profiting from the increased Relative Biological Effectiveness and Oxygen Enhancement Ratio of these projectiles with respect to proton beams. To maximise the gain in tumor control probability a precise online monitoring of the dose release is needed, avoiding unnecessary large safety margins surroundings the tumor volume accounting for possible patient mispositioning or morphological changes with respect to the initial CT scan. The Dose Profiler (DP) detector, presented in this manuscript, is a scintillating fibres tracker of charged secondary particles (mainly protons) that will be operating during the treatment, allowing for an online range monitoring. Such monitoring technique is particularly promising in the context of heavy ions PT, in which the precision achievable by other techniques based on secondary photons detection is limited by the environmental background during the beam delivery. Developed and built at the SBAI department of "La Sapienza", within the INSIDE collaboration and as part of a Centro Fermi flagship project, the DP is a tracker detector specifically designed and planned for clinical applications inside a PT treatment room. The DP operation in clinical like conditions has been tested with the proton and carbon ions beams of Trento proton-therapy center and of the CNAO facility. In this contribution the detector performances are presented, in the context of the carbon ions monitoring clinical trial that is about to start at the CNAO centre.
Collapse
Affiliation(s)
- G Traini
- Dipartimento di Fisica, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | | | | | - M G Bisogni
- INFN Sezione di Pisa, Italy; Dipartimento di Fisica "E. Fermi", Università di Pisa, Pisa, Italy.
| | - M De Simoni
- Dipartimento di Fisica, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | - Y Dong
- INFN Sezione di Milano, Italy; Dipartimento di Fisica, Università degli Studi di Milano, Italy
| | | | - M Fischetti
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | - M Magi
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | - C Mancini-Terracciano
- Dipartimento di Fisica, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | - M Marafini
- Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy; INFN Sezione di Roma, Italy
| | - R Mirabelli
- Dipartimento di Fisica, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | | | - V Patera
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - A Schiavi
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy
| | - A Sciubba
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| | - E Solfaroli Camillocci
- Dipartimento di Fisica, Sapienza Università di Roma, Italy; INFN Sezione di Roma, Italy; Scuola di Specializzazione in Fisica Medica, Sapienza Università di Roma, Roma, Italy
| | | | - A Sarti
- Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Italy; INFN Sezione dei Laboratori di Frascati, Roma, Italy; Museo Storico della Fisica e Centro Studi e Ricerche "E. Fermi", Roma, Italy
| |
Collapse
|
18
|
Russomando A, Schiariti M, Bocci V, Colandrea M, Collamati F, Cremonesi M, Ferrari M, Ferroli P, Ghielmetti F, Ghisini R, Grana C, Mancini Terracciano C, Marafini M, Mirabelli R, Morganti S, Papi S, Patanè M, Pedroli G, Pollo B, Solfaroli Camillocci E, Traini G, Faccini R. The β- radio-guided surgery: Method to estimate the minimum injectable activity from ex-vivo test. Phys Med 2019; 58:114-120. [DOI: 10.1016/j.ejmp.2019.02.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/30/2018] [Revised: 01/21/2019] [Accepted: 02/09/2019] [Indexed: 11/16/2022] Open
|
19
|
Rucinski A, Battistoni G, Collamati F, De Lucia E, Faccini R, Frallicciardi PM, Mancini-Terracciano C, Marafini M, Mattei I, Muraro S, Paramatti R, Piersanti L, Pinci D, Russomando A, Sarti A, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Voena C, Patera V. Secondary radiation measurements for particle therapy applications: charged particles produced by 4He and 12C ion beams in a PMMA target at large angle. Phys Med Biol 2018; 63:055018. [PMID: 29265011 DOI: 10.1088/1361-6560/aaa36a] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Proton and carbon ion beams are used in the clinical practice for external radiotherapy treatments achieving, for selected indications, promising and superior clinical results with respect to x-ray based radiotherapy. Other ions, like [Formula: see text] have recently been considered as projectiles in particle therapy centres and might represent a good compromise between the linear energy transfer and the radiobiological effectiveness of [Formula: see text] ion and proton beams, allowing improved tumour control probability and minimising normal tissue complication probability. All the currently used p, [Formula: see text] and [Formula: see text] ion beams allow achieving sharp dose gradients on the boundary of the target volume, however the accurate dose delivery is sensitive to the patient positioning and to anatomical variations with respect to photon therapy. This requires beam range and/or dose release measurement during patient irradiation and therefore the development of dedicated monitoring techniques. All the proposed methods make use of the secondary radiation created by the beam interaction with the patient and, in particular, in the case of [Formula: see text] ion beams are also able to exploit the significant charged radiation component. Measurements performed to characterise the charged secondary radiation created by [Formula: see text] and [Formula: see text] particle therapy beams are reported. Charged secondary yields, energy spectra and emission profiles produced in a poly-methyl methacrylate (PMMA) target by [Formula: see text] and [Formula: see text] beams of different therapeutic energies were measured at 60° and 90° with respect to the primary beam direction. The secondary yield of protons produced along the primary beam path in a PMMA target was obtained. The energy spectra of charged secondaries were obtained from time-of-flight information, whereas the emission profiles were reconstructed exploiting tracking detector information. The obtained measurements are in agreement with results reported in the literature and suggests the feasibility of range monitoring based on charged secondary particle detection: the implications for particle therapy monitoring applications are also discussed.
Collapse
Affiliation(s)
- A Rucinski
- INFN-Sezione di Roma, Italy. Dipartimento di Scienze di Base e Applicate per l'Ingegneria, Sapienza Università di Roma, Roma, Italy. Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 Krakow, Poland
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Muraro S, Battistoni G, De Lucia E, Mancini-Terracciano C, Marafini M, Mattei I, Mirabelli R, Sarti A, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Valle S, Voena C, Patera V. Abstract ID: 67 MC codes and range monitoring in particle therapy: The case of secondary charged particles. Phys Med 2017. [DOI: 10.1016/j.ejmp.2017.09.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
21
|
Giacometti V, Patera V, Mirabelli R, Pinci D, Sarti A, Sciubba A, Traini G, Battistoni G, Marafini M. Abstract ID: 1 Elastic scattering in FLUKA code for MONDO experiment: characterization of the secondary fast and ultrafast neutrons emitted in particle therapy. Phys Med 2017. [DOI: 10.1016/j.ejmp.2017.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
22
|
Marafini M, Gasparini L, Mirabelli R, Pinci D, Patera V, Sciubba A, Spiriti E, Stoppa D, Traini G, Sarti A. MONDO: a neutron tracker for particle therapy secondary emission characterisation. Phys Med Biol 2017; 62:3299-3312. [PMID: 28350543 DOI: 10.1088/1361-6560/aa623a] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Tumour control is performed in particle therapy using particles and ions, whose high irradiation precision enhances the effectiveness of the treatment, while sparing the healthy tissue surrounding the target volume. Dose range monitoring devices using photons and charged particles produced by the beam interacting with the patient's body have already been proposed, but no attempt has been made yet to exploit the detection of the abundant neutron component. Since neutrons can release a significant dose far away from the tumour region, precise measurements of their flux, production energy and angle distributions are eagerly sought in order to improve the treatment planning system (TPS) software. It will thus be possible to predict not only the normal tissue toxicity in the target region, but also the risk of late complications in the whole body. The aforementioned issues underline the importance of an experimental effort devoted to the precise characterisation of neutron production, aimed at the measurement of their abundance, emission point and production energy. The technical challenges posed by a neutron detector aimed at high detection efficiency and good backtracking precision are addressed within the MONDO (monitor for neutron dose in hadrontherapy) project, whose main goal is to develop a tracking detector that can target fast and ultrafast neutrons. A full reconstruction of two consecutive elastic scattering interactions undergone by the neutrons inside the detector material will be used to measure their energy and direction. The preliminary results of an MC simulation performed using the FLUKA software are presented here, together with the DSiPM (digital SiPM) readout implementation. New detector readout implementations specifically tailored to the MONDO tracker are also discussed, and the neutron detection efficiency attainable with the proposed neutron tracking strategy are reported.
Collapse
Affiliation(s)
- M Marafini
- INFN Sezione di Roma, Rome, Italy. Museo Storico della Fisica e Centro Studi e Ricerche 'E. Fermi', Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Marafini M, Paramatti R, Pinci D, Battistoni G, Collamati F, De Lucia E, Faccini R, Frallicciardi PM, Mancini-Terracciano C, Mattei I, Muraro S, Piersanti L, Rovituso M, Rucinski A, Russomando A, Sarti A, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Voena C, Patera V. Secondary radiation measurements for particle therapy applications: nuclear fragmentation produced by4He ion beams in a PMMA target. Phys Med Biol 2017; 62:1291-1309. [DOI: 10.1088/1361-6560/aa5307] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
24
|
Mattei I, Bini F, Collamati F, De Lucia E, Frallicciardi PM, Iarocci E, Mancini-Terracciano C, Marafini M, Muraro S, Paramatti R, Patera V, Piersanti L, Pinci D, Rucinski A, Russomando A, Sarti A, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Voena C, Battistoni G. Secondary radiation measurements for particle therapy applications: prompt photons produced by 4He, 12C and 16O ion beams in a PMMA target. Phys Med Biol 2017; 62:1438-1455. [PMID: 28114112 DOI: 10.1088/1361-6560/62/4/1438] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Charged particle beams are used in particle therapy (PT) to treat oncological patients due to their selective dose deposition in tissues with respect to the photons and electrons used in conventional radiotherapy. Heavy (Z > 1) PT beams can additionally be exploited for their high biological effectiveness in killing cancer cells. Nowadays, protons and carbon ions are used in PT clinical routines. Recently, interest in the potential application of helium and oxygen beams has been growing. With respect to protons, such beams are characterized by their reduced multiple scattering inside the body, increased linear energy transfer, relative biological effectiveness and oxygen enhancement ratio. The precision of PT demands online dose monitoring techniques, crucial to improving the quality assurance of any treatment: possible patient mis-positioning and biological tissue changes with respect to the planning CT scan could negatively affect the outcome of the therapy. The beam range confined in the irradiated target can be monitored thanks to the neutral or charged secondary radiation emitted by the interactions of hadron beams with matter. Among these secondary products, prompt photons are produced by nuclear de-excitation processes, and at present, different dose monitoring and beam range verification techniques based on prompt-γ detection are being proposed. It is hence of importance to perform γ yield measurement in therapeutic-like conditions. In this paper we report on the yields of prompt photons produced by the interaction of helium, carbon and oxygen ion beams with a poly-methyl methacrylate (PMMA) beam stopping target. The measurements were performed at the Heidelberg Ion-Beam Therapy Center (HIT) with beams of different energies. An LYSO scintillator, placed at [Formula: see text] and [Formula: see text] with respect to the beam direction, was used as the photon detector. The obtained γ yields for the carbon ion beams are compared with results from the literature, while no other results from helium and oxygen beams have been published yet. A discussion on the expected resolution of a slit camera detector is presented, demonstrating the feasibility of a prompt-γ-based monitoring technique for PT treatments using helium, carbon and oxygen ion beams.
Collapse
|
25
|
Solfaroli Camillocci E, Schiariti M, Bocci V, Carollo A, Chiodi G, Colandrea M, Collamati F, Cremonesi M, Donnarumma R, Ferrari M, Ferroli P, Ghielmetti F, Grana C, Mancini Terracciano C, Marafini M, Morganti S, Patanè M, Pedroli G, Pollo B, Recchia L, Russomando A, Toppi M, Traini G, Faccini R. First ex vivo validation of a radioguided surgery technique withβ-radiation. Phys Med 2016; 32:1139-44. [DOI: 10.1016/j.ejmp.2016.08.018] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2016] [Revised: 08/21/2016] [Accepted: 08/23/2016] [Indexed: 10/21/2022] Open
|
26
|
Rucinski A, Battistoni G, Collamati F, Collini F, De Lucia E, Faccini R, Frallicciardi P, Mancini-Terracciano C, Marafini M, Muraro S, Paramatti R, Patera V, Piersanti L, Pinci D, Russomando A, Sarti A, Sciubba A, Camillocci ES, Toppi M, Traini G, Voena C. SU-F-J-202: Secondary Radiation Measurements for Charged Particle Therapy Monitoring: Fragmentation of Therapeutic He, C and O Ion Beams Impinging On a PMMA Target. Med Phys 2016. [DOI: 10.1118/1.4956110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
27
|
Rucinski A, Battistoni G, Collamati F, Collini F, De Lucia E, Faccini R, Frallicciardi P, Mancini-Terracciano C, Marafini M, Muraro S, Paramatti R, Patera V, Piersanti L, Pinci D, Russomando A, Sarti A, Sciubba A, Camillocci ES, Toppi M, Traini G, Voena C, Rucinski A. SU-G-JeP1-13: Innovative Tracking Detector for Dose Monitoring in Hadron Therapy: Realization and Monte Carlo Simulations. Med Phys 2016. [DOI: 10.1118/1.4956988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
28
|
Toppi M, Battistoni G, Bellini F, Collamati F, De Lucia E, Durante M, Faccini R, Frallicciardi P, Marafini M, Mattei I, Morganti S, Muraro S, Paramatti R, Patera V, Pinci D, Piersanti L, Rucinski A, Russomando A, Sarti A, Sciubba A, Senzacqua M, Solfaroli Camillocci E, Traini G, Voena C. Measurement of secondary particle production induced by particle therapy ion beams impinging on a PMMA target. EPJ Web of Conferences 2016. [DOI: 10.1051/epjconf/201611705007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Bocci V, Capparella E, Collamati F, Donnarumma R, Faccini R, Ioannidis G, Limiti G, Mancini Terracciano C, Marafini M, Morganti S, Russomando A, Solfaroli Camillocci E, Toppi M, Traini G. Development of a radioguided surgery technique with beta- decays in brain tumor resection. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)30081-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Battistoni G, Collamati F, De Lucia E, Faccini R, Marafini M, Mattei I, Muraro S, Paramatti R, Patera V, Pinci D, Rucinski A, Russomando A, Sarti A, Sciubba A, Solfaroli Camillocci E, Toppi M, Traini G, Voena C. Realization of an innovative Dose Profiler for online range monitoring in particle therapy treatments. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)30212-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Donnarumma R, Bocci V, Capparella E, Collamati F, Cremonesi M, Ferrari M, Fioroni F, Grana C, Ioannidis G, Iori M, Limiti G, Mancini Terracciano C, Marafini M, Morganti S, Russomando A, Solfaroli Camilloci E, Toppi M, Traini G, Versari A, Faccini R. A novel radioguided surgery technique exploiting beta – decay. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.362] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|